Document Detail


Radionuclide Therapy via SSTR: Future Aspects from Experimental Animal Studies.
MedLine Citation:
PMID:  22572526     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
There is need for better therapeutic options for neuroendocrine tumours. The aim of this review was to summarize results of experimental animal studies and raise ideas for future radionuclide therapy based on high expression of somatostatin (SS) receptors by many neuroendocrine tumours. In summary, one of the major options is individualized treatment for each patient, including choice of SS analogues, radionuclides and treatment schedules. Other options are methods to increase the treatment effect on tumour tissue (increasing tumour uptake and retention by upregulation of receptor expression and avoiding saturation of receptor binding), methods to increase the tumour tissue response (by choice of radionuclides, SS analogues or combined therapies), and methods to reduce side effects (diminished uptake and retention in critical organs and reduced normal tissue response). Furthermore, combination therapy with other radiopharmaceuticals, cytotoxic drugs or radiosensitizers can be considered to enhance the effects of radiolabelled SS analogues.
Authors:
Eva Forssell-Aronsson; Johan Spetz; Håkan Ahlman
Related Documents :
12653976 - Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic nalt...
10497906 - Effects of kappa- and mu-opioid receptor agonists on ca2+ channels in neuroblastoma cel...
9786166 - Mu receptor and gi2alpha antisense attenuate [d-met2]-fmrfamide antinociception in mice.
1323526 - Involvement of opioid receptors in met-enkephalin modulation of blast-transformation of...
21223996 - Serotonin 2a and 2b receptor-induced phrenic motor facilitation: differential requireme...
9075256 - The dopaminergic mesencephalic projections to the hippocampal formation in the rat.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-04
Journal Detail:
Title:  Neuroendocrinology     Volume:  -     ISSN:  1423-0194     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0035665     Medline TA:  Neuroendocrinology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Affiliation:
Department of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Cancer Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship between copper and steatosis in Wilson's disease.
Next Document:  Control of crystallite orientation and size in Fe and FeCo nanoneedles.